Thiol/redox metabolomic profiling implicates GSH dysregulation in early experimental graft versus host disease (GVHD).
Graft-versus-host disease (GVHD) is a common complication of allogeneic bone marrow transplantation (BMT). Upregulation of inflammatory cytokines precedes the clinical presentation of GVHD and predicts its severity. In this report, thiol/redox metabolomics was used to identify metabolic perturbation...
Guardado en:
Autores principales: | Jung H Suh, Bindu Kanathezhath, Swapna Shenvi, Hua Guo, Alicia Zhou, Anureet Tiwana, Frans Kuypers, Bruce N Ames, Mark C Walters |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cd30e02e0ee641df88cfec7f2bde2f2d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
por: Kudakwashe Mhandire, et al.
Publicado: (2021) -
GVHD TREATMENT
por: Elif BirtaşAteşoğlu
Publicado: (2021) -
Is There a Glutathione Centered Redox Dysregulation Subtype of Schizophrenia?
por: Lena Palaniyappan, et al.
Publicado: (2021) -
Redox Switches in Noise-Induced Cardiovascular and Neuronal Dysregulation
por: Katie Frenis, et al.
Publicado: (2021) -
Antibacterial Profile of a Microbicidal Agent Targeting Tyrosine Phosphatases and Redox Thiols, Novel Drug Targets
por: Kylie White, et al.
Publicado: (2021)